Insider Trading July 1, 2026 06:51 PM

StoneX CEO Philip Smith Offloads $6.1M in Shares Following Option Exercises

Executive divestment coincides with strong Q2 earnings beat and strategic expansion plans, though revenue misses estimates.

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
SNEX

StoneX Group Inc. CEO Philip Andrew Smith executed a significant divestment of company equity, selling 51,540 shares for approximately $6.12 million on June 30, 2026. The transactions followed the exercise of stock options originally granted in December 2021. This financial activity occurs against a backdrop of mixed financial results for the second quarter of fiscal 2026, where earnings per share significantly exceeded analyst projections, but total revenue fell short of expectations. The company also announced a stock split and operational expansion in Alabama, highlighting ongoing strategic initiatives despite recent market fluctuations.

StoneX CEO Philip Smith Offloads $6.1M in Shares Following Option Exercises
SNEX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • CEO Philip Smith sold 51,540 shares for $6.12 million following the exercise of stock options originally granted in 2021.
  • StoneX Q2 fiscal 2026 earnings per share of $2.07 significantly beat the $1.34 estimate, though revenue of $829.1 million missed the $1.33 billion forecast.
  • The company announced a three-for-two stock split and plans to expand operations in Birmingham, Alabama, adding nearly 90 employees.

Philip Andrew Smith, serving as the Chief Executive Officer of StoneX Group Inc. (NASDAQ: SNEX), completed the sale of 51,540 shares of the company's common stock on June 30, 2026. The aggregate value of these transactions reached $6,119,074. These sales were executed immediately after the exercise of stock options, marking a significant movement in executive holdings.

The shares were divested across multiple transactions, with execution prices ranging between $118.667 and $118.7464 per share. The reported figures represent an average of these transactions. Detailed information regarding the specific number of shares sold at each individual price point is available upon request.

At the time of the sale, StoneX stock was trading at $123.80. This price point reflects a 9.1% decline over the preceding week. However, the stock has demonstrated substantial long-term performance, delivering a 104% return over the past year. Independent analysis from InvestingPro suggests that the stock may be overvalued at current levels, with fair value models indicating limited potential for further upside.

Before executing the sales, Mr. Smith acquired 37,500 shares of StoneX Group common stock through the exercise of stock options. The exercise price for these options was $13.34 per share, resulting in a total cost of $500,250. The original options were granted with an exercise date of December 5, 2021, and are set to expire on December 5, 2026.

Following these recent transactions, Mr. Smith's direct ownership in StoneX Group stands at 492,144 shares. Additionally, he holds 641,250 derivative securities in the form of stock options. Investors seeking deeper insights into StoneX's valuation and performance metrics can access a comprehensive Pro Research Report, which is available for StoneX and over 1,400 other US equities on InvestingPro.

In other recent developments, StoneX Group Inc. reported its second quarter earnings for fiscal year 2026. The company significantly surpassed earnings expectations, achieving an earnings per share of $2.07, which outperformed the projected $1.34. Despite this earnings success, StoneX's revenue of $829.1 million fell short of the anticipated $1.33 billion.

The company also announced a three-for-two stock split, which will be executed as a stock dividend. Stockholders of record by July 7, 2026, will receive one additional share for every two shares owned after trading closes on July 17, 2026. StoneX also revealed plans to expand its operations in Birmingham, Alabama, with the addition of nearly 90 employees over the next three to five years. The company will occupy a new 46,000-square-foot office in the Protective Center, featuring conference rooms and collaboration areas. These developments highlight the company's ongoing strategic initiatives and operational growth.

Risks

  • Revenue miss in Q2 fiscal 2026 suggests potential challenges in top-line growth despite strong profitability.
  • Stock appears overvalued according to fair value models, indicating limited upside potential for investors.
  • Executive divestment of significant share volume may signal internal valuation perceptions or liquidity needs.

More from Insider Trading

REGENXBIO's CMO Executes Pre-Arranged Stock Sales Amid Clinical Milestones Jul 1, 2026 Atlanticus Holdings Insider Activity: Frank J Hanna III Liquidates Partial Stake Jul 1, 2026 Oruka Therapeutics COO Laura Sandler Executes $472K Stock Sale Amid Valuation Concerns Jul 1, 2026 Atlanticus Holdings Chairman Executes Multi-Day Share Sale Jul 1, 2026 RH Insider Activity: Director Carlos Alberini Accumulates $1.83M in Stock Amid Mixed Analyst Outlook Jul 1, 2026